Gen9

Acquired

Gen9 is a biotech company in Cambridge, United States, founded in 2009. It has raised $21.0M across 1 round, most recently a $21.0M Series C in April 2013.

Gen9 Genetics - DNA primer design, cDNA libraries, qPCR

Employees
11–50
Founded
2009
Business Model
B2B
Total Funding
$21.0M
Last Round
$21.0M Series CApr 2013
Rounds
1
Acquisition Date
Jan 2017

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Gen9 was a Cambridge, Massachusetts-based synthetic biology company that pioneered high-throughput, chip-based DNA synthesis and assembly technology. The company used silicon chip fabrication techniques to dramatically reduce the cost and accelerate the production of DNA constructs, enabling researchers to create gene-length DNA sequences at scale. Founded with roots in Harvard University's synthetic biology research community, Gen9 attracted venture investment and served pharmaceutical, academic, and industrial biotech customers. The company was acquired by Ginkgo Bioworks in January 2017, with its DNA synthesis technology integrated into Ginkgo's organism engineering platform.

Summary

It lists 11–50 employees. It has raised $21.0M in total across 1 round, most recently a $21.0M Series C round in Apr 2013. Investors include Ginkgo Bioworks and Agilent Technologies.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionJan 2017

Sign up to see all 2 events

Funding: Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Gen9 on Indexed.vc
<a href="https://indexed.vc/companies/gen9"><img src="https://indexed.vc/api/badge/company/gen9" alt="Gen9 on Indexed.vc" width="260" height="76" /></a>